SCHEMBL22492234

SCHEMBL22492234

CN(C(=O)O)c1cccc(S(=O)(=O)Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA9 Q16790 1/20 0.40
GAA P10253 1/20 0.38
HSD17B1 P14061 2/20 0.38
HSD17B2 P37059 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
NR1H3 Q13133 1/20 0.37
HSD11B1 P28845 1/20 0.37
MAPK1 P28482 1/20 0.36
HDAC3 O15379 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3112756 0.80 CA12 (0.53) ALDH1A1HSD17B10TDP1LMNACA12
SCHEMBL29566450 0.80 CA12 (0.53) ALDH1A1HSD17B10TDP1LMNACA12
SCHEMBL22492259 0.80 CYP1A2 (0.42) ALDH1A1LMNAHTTSMN1; SMN2CA12
SCHEMBL29616698 0.79 BRD4 (0.47) ALDH1A1LMNAHTTSMN1; SMN2HSD17B1
SCHEMBL1603124 0.79 BRD4 (0.47) ALDH1A1LMNAHTTSMN1; SMN2HSD17B1
SCHEMBL17845289 0.79 ALDH1A1 (0.45) ALDH1A1HSD17B10TDP1CA12CA1
SCHEMBL22549340 0.77 ALDH1A1 (0.46) ALDH1A1HSD17B10TDP1LMNAHTT
SCHEMBL2096198 0.75 HTR3E (0.61) ALDH1A1LMNAHTTSMN1; SMN2GAA
SCHEMBL31715773 0.75 HTR3E (0.61) ALDH1A1LMNAHTTSMN1; SMN2GAA
Sulfuric Acid SCHEMBL27347184 0.75 HSD17B1 (0.51) ALDH1A1HSD17B10LMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357208-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. (US) 2023-11-09 US disclosed
US-11685732-B2 MYST family histone acetyltransferase inhibitors Epizyme, Inc. (US) 2023-06-27 US disclosed
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. 2022-05-26 US disclosed
EP-3716964-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. (US) 2020-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS EP300, KAT2A, KAT6A ALDH1A1 2786/4885HSD17B10 1572/4885TDP1 1085/4885
US-20230357208-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS EP300, KAT2A, KAT6A ALDH1A1 2786/4885HSD17B10 1572/4885TDP1 1085/4885
US-11685732-B2 MYST family histone acetyltransferase inhibitors EP300, KAT2A, KAT6A ALDH1A1 2786/4885HSD17B10 1572/4885TDP1 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.